Rayzebio
3 known investors
RayzeBio develops radiopharmaceutical therapies for cancer treatment. The company is a subsidiary of Bristol Myers Squibb focused on advancing targeted cancer therapies to patients.
BiotechHealthtechMedical Devices
Founders & leadership
BH
Ben HickeyPresident
AB
Abhi Bhat, PhDSenior Vice President, Research & Development